CellaVision expands the utility of the CellaVision DM96 digital morphology system
Two new products to be launched at the Medica Exhibition in Düsseldorf on 14th of November
CellaVision, which develops and sells digital morphology products for the routine analysis of blood, widens its product offering to clinical laboratories by launching a new application for the analysis of body fluids, including cerebrospinal, synovial and pleural fluids. In addition, a new version of the blood application will be launched, now offering a way to digitize an entire slide.
"We see a great demand amongst our clients for the type of functions that CellaVision can now offer. To be able to analyze blood and other body fluids in a safe, efficient, and comfortable way is surely the ideal solution for many laboratories," says Yvonne Mårtensson, CEO of CellaVision. "The ability to scan full slides is an additional service offered to laboratories which will give us an opportunity to further evaluate the market needs in other imaging segments, such as Pathology and Cytology."
Using CellaVision's application for body fluids, clinical laboratories are now able to analyze and assess cells in spinal fluid, synovial fluid, and pleural fluid. The advantages of the new application are the same as those for blood - faster and more standardized results, digital archiving of samples together with patient records, as well as sharing of digital images with experts outside the laboratory.
A new function has been added to software version 2.0 of CellaVision's application for peripheral blood which makes it now possible to capture digital images of any desired area of slides, creating a Digital Slide. Although primarily designed for Hematology smears, the digitalization function is also applicable to other types of specimens, for educational purposes. It gives a useful overview of the sample and allows for discussion between physicians regardless of physical location.
CellaVision will present the new products at the Medica, one of the world's largest medical technology conventions, in Düsseldorf, Germany, between the 14th and 17th of November. CellaVision will display its products in HALL 1, booth A32. The company's distributor, Sysmex, will also display the products.
The application for body fluids will be offered as a separate product while the function for digital scanning of samples is included in the company's most recent software version for peripheral blood. Both functions are available for the CellaVision(TM) DM96 analyzer and will be commercially available in Europe in the beginning of 2008. An application to the Food and Drug Administration (FDA) concerning sales of the body fluids application in the US will be submitted at the same time.
For more information, please contact:
Yvonne Mårtensson, CEO, CellaVision AB
CellaVision AB develops, markets, and sells market-leading systems for performing automatic identification of white blood cells, characterization of red blood cell morphology, and software for education and competency assessment. The company's core competencies are in advanced imaging analysis, artificial intelligence, and automated microscopy, resulting in the development of software and hardware for automatic image analysis of cells and cell changes, with applications in healthcare.
The company headquarters are in Lund, Sweden and has subsidiaries in Jupiter, FL, USA, and Toronto, ON, Canada. For more information, visit www.cellavision.com
CellaVision's share is listed on First North at the OMX Stockholm Stock Exchange. The company's Certified Advisor is Remium AB.